CBD may have strong benefits – but does it need help from other cannabinoids?
The question is one of the hottest topics in cannabis as extractors see the markets shifting for different kinds of extracts. Beauty retailing behemoth Sephora announced earlier this year that it would stock only full- or broad-spectrum CBD products.
Some cheered, calling it validation of the alleged “entourage effect” — synergy among the cannabis plant’s dozens of cannabinoids — and a win for whole-plant-products. Others point out that the “entourage effect” remains unsettled science and that isolated CBD has therapeutic benefits and is best for precise dosing.
The debate has hemp growers and processors wondering where the market is headed.
The clock is ticking to register for this webinar, scheduled for 1 p.m. ET/10 a.m. PT on Thursday. We’ll hear from CBD manufacturers who say isolate products’ days are numbered, versus those who say the market for isolate isn’t going anywhere. After the manufacturers make their cases for the future of CBD extraction, you’ll get a chance to weigh in on where you see the industry headed.
Register for the webinar here, and feel free to email questions before the event to [email protected]
